stockrowSOPHiA GENETICS SA
SOPH Healthcare Health Information Services
SOPHiA GENETICS SA’s revenue for fiscal 2025 (year ended December 2025) was $77.3 million, up 18.6% from fiscal 2024.
- Revenue
- +24.7%
- EPS
- +21.0%
- Free cash flow
- −1.87%
- Total debt
- +1.19%
Quarter to September 2026, against a year earlier
Follow SOPH
Alert me
SOPHiA GENETICS SA (SOPH) EV/Sales
As of 5 November 2026, SOPHiA GENETICS SA (SOPH) trades at a EV/Sales of 5.8×. Over the past ten years it has ranged from −1.7× (June 2022) to 26.6× (August 2021); the current reading is higher than 83% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 3.8× | 80.71% |
| FY2024 | 2.1× | (36.17%) |
| FY2023 | 3.3× | — |
| FY2022 | −0.4× | — |
| FY2021 | 13.0× | (41.39%) |
| FY2020 | 22.2× | 0.00% |
| FY2019 | 22.2× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 7.4× | 73.14% |
| Jun 2026 | 4.3× | 3.12% |
| Mar 2026 | 4.1× | 8.67% |
| Dec 2025 | 3.8× | (3.76%) |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| EVH Evolent Health, Inc compare | 0.6× |
| PHR Phreesia, Inc. compare | 1.7× |
| GDRX GoodRx Holdings, Inc. compare | 1.8× |
| HSTM HealthStream, Inc. compare | 2.4× |
| OMDA Omada Health, Inc. compare | 3.0× |
| NRC National Research Corporation compare | 4.5× |
| CTEV Claritev Corporation compare | 5.0× |
| CARL Carlsmed, Inc. compare | 5.4× |
| SOPH SOPHiA GENETICS SA | 5.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)